1. Shafiei E, Fouladi Z, Shafiei P. The safe interval time of crystalloid cardioplegic solution transfusion during CABG. Iran South Med J. 2015; 18(1) :71-79.
2. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease an update. Hypertension 2001; 37(4): 1053-9. [
DOI:10.1161/01.HYP.37.4.1053]
3. Pjanic M, Miller CL, Wirka R, et al. Genetics and genomics of coronary artery disease. Curr Cardiol Rep 2016; 18(10): 102. [
DOI:10.1007/s11886-016-0777-y]
4. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25(1): 29-38. [
DOI:10.1161/01.ATV.0000150649.39934.13]
5. Qin B, Yang H, Xiao B, et al. Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep 2012; 39(4): 4509-18. [
DOI:10.1007/s11033-011-1241-0]
6. Konior A, Schramm A, Czesnikiewicz-Guzik M, et al. NADPH oxidases in vascular pathology. Antioxid Redox Signal 2014; 20(17): 2794-814. [
DOI:10.1089/ars.2013.5607]
7. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension clinical implications and therapeutic possibilities. Diabetes Care 2008; 31 Suppl 2: S170-80. [
DOI:10.2337/dc08-s247]
8. Kikuchi H, Hikage M, Miyashita H, et al. NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene 2000; 254(1-2): 237-43. [
DOI:10.1016/S0378-1119(00)00258-4]
9. Uenno N, Takeya R, Miyano K, et al. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem 2005; 280(24): 23328-39. [
DOI:10.1074/jbc.M414548200]
10. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994; 266(6 Pt 2): H2568-72.
11. Sorescu D, Weiss D, Lassègue B, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105(12): 1429-35. [
DOI:10.1161/01.CIR.0000012917.74432.66]
12. Liang B, Wei Q, Shen T, et al. The A640G polymorphism in the NAD (P) H oxidase p22phox gene (CYBA) is associated with risk reduction of coronary heart disease: a meta-analysis. Clin Biochem 2014; 47(6):409-16 [
DOI:10.1016/j.clinbiochem.2013.12.001]
13. Najafi M, Alipoor B, Shabani M, et al. Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD (P) H oxidase p22phox gene and severity of stenosis in coronary arteries. Gene 2012; 499(1): 213-7. [
DOI:10.1016/j.gene.2012.02.032]
14. Hu P, Huang MY, Hu XY, et al. Meta-analysis of C242T polymorphism in CYBA genes: risk of acute coronary syndrome is lower in Asians but not in Caucasians. J Zhejiang Univ Sci B 2015; 16(5): 370-9. [
DOI:10.1631/jzus.B1400241]
15. Green MR, Sambrook J. Molecular Cloning: a Laboratory Manual. 4th ed. New York: Cold Spring Harbor Laboratory Press, 2012, 104-111
16. Pollock A, Jones DS. Coronary artery disease and the contours of pharmaceuticalization. Soc Sci Med 2015; 131: 221-7. [
DOI:10.1016/j.socscimed.2014.06.035]
17. Raygan F, Karimian M, Rezaeian A, et al. Angiotensinogen-M235T as a risk factor for myocardial infarction in Asian populations: a genetic association study and a bioinformatics approach. Croat Med J 2016; 57(4): 351-62. [
DOI:10.3325/cmj.2016.57.351]
18. Mazaheri M, Karimian M, Behjati M, et al. Association analysis of rs1049255 and rs4673 transitions in p22phox gene with coronary artery disease: A case-control study and a computational analysis. Ir J Med Sci 2017; 1-8. [
DOI:10.1007/s11845-017-1601-4]
19. McClelland RL, Jorgensen NW, Budoff M, et al. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study). J Am Coll Cardiol 2015; 66(15): 1643-53. [
DOI:10.1016/j.jacc.2015.08.035]
20. Niemiec P, Nowak T, Iwanicki T, et al. The -930A> G polymorphism of the CYBA gene is associated with premature coronary artery disease. A case–control study and gene-risk factors interactions. Mol Bio Rep 2014; 41(5): 3287-94. [
DOI:10.1007/s11033-014-3191-9]
21. Nowak T, Niemiec P, Górczyńska-Kosiorz S, et al. The CYBA gene 49A> G polymorphism (rs7195830) is associated with hypertension in patients with coronary artery disease. Biomed Res Int 2016; 2016: 1539671. [
DOI:10.1155/2016/1539671]
22. Zalba G, San José G, Moreno MU, et al. NADPH oxidase-mediated oxidative stress: genetic studies of the p22phox gene in hypertension. Antioxid Redox Signal 2005; 7(9-10): 1327-36. [
DOI:10.1089/ars.2005.7.1327]
23. Zalba G, Beaumont FJ, San José G, et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35(5): 1055-61. [
DOI:10.1161/01.HYP.35.5.1055]
24. Karimian M, Hosseinzadeh Colagar A. Human MTHFR-G1793A transition may be a protective mutation against male infertility: a genetic association study and in silico analysis. Hum Fertil 2017; 1-9.